SEC Form 4 · accession 0001127602-15-027745
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Bollag
Officer — Sr. VP, Reg. Affairs & Quality
Period of report
Sep 24, 2015
Accepted (ET)
Sep 28, 2015 · 6:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 24, 2015 | M | 10,000 | $0.00 | A | 131,797 | D | |
| Common Stock | Sep 28, 2015 | S | 5,000 | $6.4631 | D | 126,797 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance stock unitF1,F2,F3 | — | Sep 24, 2015 | M | 10,000 | D | — | — | Common Stock | 10,000 | 10,000 | D |
| Performance stock unitF1,F2,F3 | — | Sep 24, 2015 | A | 20,000 | A | — | — | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1Each performance stock unit represents a right to receive one share of ARIAD common stock.
- F2Each performance stock unit represents a right to receive one share of ARIAD common stock.
- F3The performance stock units vest as to 50% of the award on 7/15/2013 and as to 25% on each of 7/15/2014 and 7/15/2015.